The long‐term therapeutic effects of His‐Purkinje system pacing on bradycardia and cardiac conduction dysfunction compared with right ventricular pacing: A systematic review and meta‐analysis. (28th March 2020)

• Record Type: Journal Article
• Authors: Sun, Jin‐Yu; Sha, Ye‐Qin; Sun, Qing‐Yang; Qiu, Yue; Shao, Bo; Ni, Yi‐Hong; Mei, Yu‐Kun; Zhang, Chang‐Ying; Wang, Ru‐Xing
• Is Part Of: Journal of cardiovascular electrophysiology. Volume 31:Number 5(2020)
• Page Start: 1202
• Page End: 1210
• Publication Date: 2020-03-28
• Subjects: clinical outcomes -- His bundle pacing -- His‐Purkinje system pacing -- left bundle branch pacing -- meta‐analysis; Blood vessels -- Physiology -- Periodicals; Electrophysiology -- Periodicals; Heart -- Physiology -- Periodicals; 612.1
• DOI: 10.1111/jce.14445
• Languages: English
• ISSNs: 1045-3873

Abstract

Abstract: Aims: His‐Purkinje system pacing has been demonstrated as a synchronized ventricular pacing strategy via pacing His‐Purkinje system directly, which can decrease the incidence of adverse cardiac structure alteration compared with right ventricular pacing (RVP). The purpose of this meta‐analysis was to compare the effects of His‐Purkinje system pacing and RVP in patients with bradycardia and cardiac conduction dysfunction. Methods: PubMed, Embase, Cochrane Library, and Web of Science were systematically searched from the establishment of databases up to 15 December 2019. Studies on long‐term clinical outcomes of His‐Purkinje system pacing and RVP were included. Chronic paced QRS duration, chronic pacing threshold, left ventricular ejection fraction (LVEF), left ventricular end‐diastolic volume (LVEDV), left ventricular end‐systolic volume (LVESV), all‐cause mortality, and heart failure hospitalization were collected for meta‐analysis. Results: A total of 13 studies comprising 2348 patients were included in this meta‐analysis. Compared with RVP group, patients receiving His‐Purkinje system pacing showed improvement of LVEF (mean difference [MD], 5.65; 95% confidence interval [CI], 4.38‐6.92), shorter chronic paced QRS duration (MD, − 39.29; 95% CI, − 41.90 to − 36.68), higher pacing threshold (MD, 0.8; 95% CI, 0.71‐0.89) and lower risk of heart failure hospitalization (odds ratio [OR], 0.65; 95% CI, 0.44‐0.96) during the follow‐up. However, no statistical difference existed in LVEDV, LVESV and all‐cause mortality between the two groups. Conclusion: Our meta‐analysis suggests that His‐bundle pacing is more suitable for the treatment of patients with bradycardia and cardiac conduction dysfunction.